Working hypotheses for the creation of new potential drugs including Class III antiarrhythmic (nibentan, niferidyl), antiallergic (theoritin), and antituberculosis (hixozid) agents are formulated and experimental data on the activity of the obtained compounds are presented.
Similar content being viewed by others
References
R. G. Glushkov, S. P. Golitsyn, E. V. Dorodnikova, et al., Vestn. Ross. Akad. Med. Nauk, No. 11, 38–42 (1998).
R. G. Glushkov, M. D. Mashkovski, and S. D. Yuzhakov, Drugs Future, 22, 30–33 (1997).
R. G. Glushkov, S. D. Yuzhakov, A. I. L?vov, et al., Khim.-farm. Zh., 45(2), 3–12 (2011).
R. G. Glushkov and A. I. L’vov, RF Pat. No. 2059612, “Method for preparing 1-phenyl-(1-p-nitrobenzoylamino)-5-N,N-diethylaminopentane and 1-phenyl-1-amino-5-N,N-diethylaminopentane hydrochloride”; Byull. Izobret., No. 13 (1996).
M. D. Mashkovski, R. G. Glushkov, S. Ya. Skachilova, et al., SU Pat. No. 1833612, “1-Phenyl-1-(p-nitrobenzoylamino)-5-N-piperidino)- or (N,N-diethylamino)pentane hydrochlorides exhibiting anti-arrhythmic and antifibrillatory activity” (1987).
M. D. Mashkovski, R. G. Glushkov, E. V. Dorodnikova, et al., Khim.-farm. Zh., 29(3), 27–31 (1995).
L. V. Rozenshtraukh and E. P. Anyukhovskii, Kardiologiya, 35(5), 25–36 (1995).
E. B. Maikov, S. A. Bakalov, I. B. Krutanov, et al., Kardiologiya, 36(6), 38–51 (1996).
M. Ya. Ruda, I. N. Merkulova, A. E. Tararak, et al., Kardiologiya, 36(6), 28–37 (1996).
E. B. Maikov, S. A. Bakalov, I. B. Krutanov, et al., Kardiologiya, 35(5), 10–18 (1995).
R. G. Glushkov and S. D. Yuzhakov, Khim.-farm. Zh., 45(1), 3–13 (2011).
R. G. Glushkov and S. D. Yuzhakov, RF Pat. No. 2,333,212, “Derivatives of 1- and 7-[omega-(benzhydryl-4-piperazinyl-1)alkyl]xanthines exhibiting antihistamine and anti-allergic activity”; Byull. Izobret., No. 25 (2008).
M. D. Mashkovskii, Drugs [in Russian], Novaya Volna, Moscow (2005), p. 292.
R. G. Glushkov, M. I. Perel’man, G. B. Sokolova, et al., RF Pat. No. 2209067, “Combined antituberculosis drugs as a composite of quinoxalin-1,4-dioxide derivatives with known antituberculosis drugs”; Byull. Izobret., No. 21 (2003).
R. G. Glushkov, G. B. Sokolova, L. Yu. Krylova, et al., Probl. Tuberk. Bolezn. Legk., No. 3, 20–25 (2007).
R. G. Glushkov and G. B. Sokolova, Antibiot. Khimioter., 53(5–6), 11–13 (2008).
Author information
Authors and Affiliations
Additional information
* S. D. Yuzhakov, deceased.
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 45, No. 9, pp. 3–7, September, 2011.
Rights and permissions
About this article
Cite this article
Glushkov, R.G., Yuzhakov*, S.D. Experience in creating new drugs using traditional technologies. Pharm Chem J 45, 517–521 (2011). https://doi.org/10.1007/s11094-011-0670-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-011-0670-3